Article
MYST acetyltransferases are a targetable therapeutic vulnerability in SETBP1-mutant leukemia
2026-01-08
Abstract excerpt
Mutations in SET binding protein 1 ( SETBP1 ) are associated with an adverse prognosis in myeloid malignancies. These mutations stabilize SETBP1 protein, driving increased expression of a progenitor-associated gene expression program through incompletely described mechanisms. A proteomic screen revealed interactions between SETBP1 and members of the MYST acetyltransferase complexes, including the catalytic subuni...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a046f1a9-9cba-585b-8f58-6cc697750e19
- DOI
- 10.64898/2026.01.08.697228
